Tumor Marker Testing Market, 2019-2023: Supplier Shares by Product and Country, Emerging Technologies, Strategic Profiles of Leading Suppliers

Tumor Marker Testing Market, 2019-2023: Supplier Shares by Product and Country, Emerging Technologies, Strategic Profiles of Leading Suppliers

  • July 2019 •
  • 185 pages •
  • Report ID: 5797493 •
  • Format: PDF
Tumor Marker Testing Market, 2019-2023: Supplier Shares by Product and Country, Emerging Technologies, Strategic Profiles of Leading Suppliers

This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.

The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in RandD, collaborative arrangements and business strategies.

Contains 185 pages


Companies Profiled
Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako